Outil de recherche d'opportunités de financement
2021-2027 correspond à une nouvelle période-cadre financière pluriannuelle établie par la Commission européenne avec des programmes de financement nouveaux ou adaptés. Horizon Europe, Erasmus +, Interreg funding sont quelques-uns des Programmes de nouvelles sources de financement intéressantes pour les acteurs de la santé et de l’impression 3D. En outre, il existe d’autres sources de financement privées disponiblese.
L’outil de recherche d’opportunités de financement CARDIOPATCH fournit le dernier appel de propositions public et privé disponible. Si vous êtes à la recherche de possibilités de financement, cet outil vous aidera!
Référence
Source de financement
Portée géographique
Type de financement
Date limite (de / à)
Mots clés
EMBO Advanced Collaboration Grants
Référence: Indisponible
Source de financement: EMBO
Portée géographique: International
Type de financement: Financement privé
Date limite: 31/12/2022
The goal of the EMBO Advanced Collaboration Grants is to support group leaders in participating countries, in EMBO subject areas, to engage in international collaboration to strengthen their laboratory’s research efforts.
ERC SYNERGY GRANTS 2023
Portée géographique: Européen
Type de financement: Financement publique
Date limite: 08/11/2022
Grants for projects that require the skills and resources of several Principal Investigators (minimum two and maximum four) to address ambitious and disruptive research problems in any area of knowledge. Projects must be carried out in a European or Associated country. The application must demonstrate that the proposed research cannot be carried out by a single Principal Investigator.
R&D&I projects linked to personalised medicine and advanced therapies
Portée géographique: National (Espagne)
Type de financement: Financement publique
Date limite: 26/10/2022
The aim of this call is the financing of R+D+I projects linked to Personalised Medicine and Advanced Therapies to the industry environment
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)
Référence: PAR-19-173
Source de financement: National Institutes of Health (NIH)
Portée géographique: International
Type de financement: Financement publique
Date limite: 08/05/2022
This funding opportunity announcement encourages state-of-the-art, systematic research approaches to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases.
Bioengineering Research Grant (BRG) (R01 Clinical Trial Not Allowed)
Référence: PAR-19-158
Source de financement: National Institutes of Health (NIH)
Portée géographique: International
Date limite: 07/05/2022
The goal for a bioengineering research grant (BRG) is to foster the development of an innovative technology, model, technique, design, or method that has the potential for significant impact on biomedical research.
